Global Pediatric Antiretroviral Commitment-to-Action Public Recognition Award
About the Commitment-to-Action (CTA) Launched in December 2014, and supported by: Aims to increase children’s access to HIV treatment, by accelerating the development and introduction of the most important pediatric ARVs
CTA Public Recognition Awards Two awards recognizing exceptional efforts to expand children’s access to HIV/AIDS treatment through the development and uptake of highest priority pediatric ARVs One award recognizes a pharmaceutical company, and one award recognizes a national AIDS program Launched on World AIDS Day 2015, with nominations collected earlier this year for the pharmaceutical award And the winner is…
CTA Public Recognition Award 2016 Pharmaceutical Company ViiV Healthcare For exceptional efforts to fast-track development of the most needed pediatric ARVs
Nominations for the second Public Recognition Award are now open The award for the national HIV program will be awarded later this year on World AIDS Day 2016 Nominate the national HIV program that you believe has made the most progress in improving uptake of high-priority pediatric ARVs Search Twitter hashtag, #PedsAward, for more information and link to nomination forms Deadline for nominations is September 1, 2016